Galmed Pharmaceuticals Ltd. buy Barclays PLC
Start price
24.02.25
/
50%
€6.40
Target price
24.02.26
€98.39
Performance (%)
-
End price
25.02.26
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Galmed Pharmaceuticals Ltd. | - | - | - |
| iShares Core DAX® | -1,31 % | -0,78 % | 9,15 % |
| iShares Nasdaq 100 | 1,98 % | -2,04 % | 6,57 % |
| iShares Nikkei 225® | 0,59 % | 6,71 % | 31,58 % |
| iShares S&P 500 | 1,42 % | -0,48 % | 3,62 % |
Comments by Barclays_PLC for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Barclays PLC from $100.00 to $103.00. They now have an "overweight" rating on the stock.
Ratings data for GMED provided by MarketBeat
In the thread Trading Galmed Pharmaceuticals Ltd.
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten
Current prediction by Barclays_PLC for Galmed Pharmaceuticals Ltd.
Stopped prediction by Barclays_PLC for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
25.02.26
25.02.26
€104.35
25.02.27
25.02.27
-
19.09.24
19.09.24
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
10.11.25
10.11.25
€98.63
10.11.26
10.11.26
-
19.09.24
19.09.24
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.27
08.08.24
08.08.24
€85.19
08.08.25
08.08.25
2270.37%
09.08.25
09.08.25
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.40
09.05.24
09.05.24
€78.88
09.05.25
09.05.25
1516.16%
10.05.25
10.05.25